The ROE as of September 2024 (TTM) for Humanigen, Inc. (HGEN) is 46.59%

According to Humanigen, Inc.’s latest financial reports and current stock price. The company's current ROE is 46.59%. This represents a change of 79.55% compared to the average of 25.95% of the last 4 quarters.

Humanigen, Inc. (HGEN) Historical ROE (quarterly & annually)

How has HGEN ROE performed in the past?

The mean historical ROE of Humanigen, Inc. over the last ten years is 105.51%. The current 46.59% ROE has changed -55.84% with respect to the historical average. Over the past ten years (40 quarters), HGEN's ROE was at its highest in in the September 2016 quarter at 2.44%. The ROE was at its lowest in in the March 2016 quarter at -1761.69%.

Humanigen, Inc. (HGEN) ROE by Quarter and Year

Discovering the peaks and valleys of Humanigen, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Humanigen, Inc. (HGEN) Average ROE

How has HGEN ROE performed in the past?

The current ROE of Humanigen, Inc. (HGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Humanigen, Inc. (HGEN) ROE vs. Peers

How is HGEN’s ROE compared to its peers?

Humanigen, Inc.’s ROE is less than Acer Therapeutics Inc. (0%), less than NRx Pharmaceuticals, Inc. (196.73%), less than Pasithea Therapeutics Corp. (193.11%), greater than SAB Biotherapeutics, Inc. (-74.63%), greater than Windtree Therapeutics, Inc. (-94.04%), greater than Dermata Therapeutics, Inc. (-123.93%), greater than Ensysce Biosciences, Inc. (-197.44%), greater than Panbela Therapeutics, Inc. (-705.90%), less than Baudax Bio, Inc. (545.45%), less than Avenue Therapeutics, Inc. (54.54%), greater than Hoth Therapeutics, Inc. (-749.10%), greater than Revelation Biosciences, Inc. (-81.79%), greater than NeuroBo Pharmaceuticals, Inc. (-243.91%), greater than Virax Biolabs Group Limited (-154.04%), greater than Cardio Diagnostics Holdings, Inc. (-115.10%), greater than NovaBay Pharmaceuticals, Inc. (-308.99%), greater than Oncorus, Inc. (-431.13%), greater than eFFECTOR Therapeutics, Inc. (-130.61%), less than Apollomics, Inc. (2.18%), greater than Angion Biomedica Corp. (-184.11%), greater than Sigilon Therapeutics, Inc. (-113.71%), greater than null (-81.98%),

Build a custom stock screener for Humanigen, Inc. (HGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Humanigen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Humanigen, Inc. (HGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Humanigen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.